Views from the
regulatory cockpit

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions

Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers

Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst...